ストックスクリーナーアプリを入手
0.393
2.82%
-0.0114
アフターアワーズ：
.38
-0.013
-3.31%
Nexalin Technology Inc (NXL) 最新ニュース
Exclusive: Nexalin Brazil trial shows benefits across anxiety, sleep and quality of life - MSN
Nexalin reports positive results from anxiety disorder trial By Investing.com - Investing.com Nigeria
NXL Should I Buy - Intellectia AI
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life - Sahm
Nexalin Technology, Inc. (NXL) stock price, news, quote and history - Yahoo Finance Australia
Nexalin Technology Q1 2026 Earnings: Wider-than-Expected Loss but Stock Gains 2%ROA Comparison - newsline.com
NXL Q1 2026 Earnings: EPS Misses Estimates, Stock Gains Despite Wider LossEarnings Surprise Score - newsline.com
Nexalin reports positive clinical trial results for anxiety and insomnia - grafa.com
Nexalin reports positive results from anxiety disorder trial - Investing.com UK
Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial - Moomoo
Nexalin Technology, Inc. Reports Successful Clinical Trial Results for Non-Invasive Neurostimulation Treatment of Anxiety and Depression - Quiver Quantitative
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sale - GlobeNewswire
Nexalin receives U.S. patent for neurostimulation method - Investing.com UK
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia - markets.businessinsider.com
Nexalin receives U.S. patent for neurostimulation method By Investing.com - Investing.com South Africa
Nexalin Technology Announces Issuance of U.S. Patent - GlobeNewswire
New brain stimulation patent targets anxiety, depression, insomnia - Stock Titan
Nexalin Technology | 8-K: Current report - Moomoo
Nexalin Acquires Digital Health Platform Ahead of FDA Pivotal Trial for Insomnia Treatment - Sleep Review
Nexalin Technology (NXL) Surges 16%: Breakout Potential Above ResistanceValue ETF - The Legal Advocate
Nexalin Technology earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Nexalin Technology earnings beat, revenue fell short of estimates - Investing.com
Nexalin Technology Q1 2026 Earnings: EPS Misses Estimates Amidst Narrowing LossesProfit Margin Analysis - The Legal Advocate
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Company Intensifies R&D SpendSegment Revenue Breakdown - newsline.com
Nexalin Technology, Inc.Common Stock (NQ: NXL - The Chronicle-Journal
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury - Sahm
Nexalin Technology (NXL) Surges 19% as Momentum Builds Toward Key ResistanceWave Equality - The Legal Advocate
Nexalin Technology (NXL) Q1 2026 Profit Slips to $-0.11 — Misses Analyst ForecastsFiscal Year Earnings - The Legal Advocate
House committee directs VA to research brain stimulation for TBI By Investing.com - Investing.com Australia
House committee directs VA to research brain stimulation for TBI - Investing.com
Maxim Group Maintains Nexalin Technology(NXL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Nexalin Technology Secures Key Neurostimulation Legislative - GlobeNewswire
Nexalin Technology (NXL) Q1 2026 Earnings Miss: EPS $-0.11 vs $-0.10 ExpectedSaaS Earnings Trends - The Legal Advocate
Nexalin Acquires PONM to Expand AI Health Platform - TipRanks
Nexalin Acquires PONM for $1.3 Million in Stock, Adds 24-Month GLV Collaboration - TradingView
Nexalin (NXL) acquires PONM AI health platform in $1.3M stock deal - Stock Titan
Nexalin acquires digital health platform PONM for $1.3M - Investing.com India
Nexalin acquires digital health platform PONM for $1.3M By Investing.com - Investing.com South Africa
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial - The Manila Times
Nexalin Acquires AI-Integrated Digital Health Platform - GlobeNewswire
Nexalin Technology, Inc. acquired PONM, Inc. from GreenLight Ventures, LLC for $1.3 million. - marketscreener.com
Nexalin Technology (NXL) Trading at $$0.34 — Key Decision Point 2026-05-14Popular Trader Picks - Newser
TradingKey - TradingKey
Number of shareholders of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
NXL Financials: Income Statement, Balance Sheet & Cash Flow | Nexalin Tech - Stock Titan
Nexalin Technology, Inc. 1Q 2026: Revenue $14.95K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nexalin Technology (NXL) Q1 loss, cash burn and Nasdaq bid-price warning - Stock Titan
Peer-Reviewed Neuroimaging Data Supports Nexalin’s Technology for Chronic Insomnia - Sleep Review
Nexalin Technology Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
MSN Money - MSN
1.21%
1.43%
大文字化:
|
ボリューム (24 時間):